TRAVERE THERAPEUTICS INC's ticker is and the CUSIP is 89422GAA5. A total of 26 filers reported holding TRAVERE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Context Capital Management, LLC | 41,167 | $26,722 | 2.14% |
SILVERBACK ASSET MANAGEMENT LLC | 12,500,000 | $8,093,188 | 1.11% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 26,500,000 | $17,217,315 | 0.72% |
BRAIDWELL LP | 28,350,000 | $18,393,480 | 0.58% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 25,000,000 | $16,144,712 | 0.41% |
WOLVERINE ASSET MANAGEMENT LLC | 45,400,000 | $29,373,729 | 0.33% |
Lion Point Capital, LP | 1,000,000 | $647,930 | 0.29% |
Segantii Capital Management Ltd | 7,500,000 | $4,873,085 | 0.17% |
READYSTATE ASSET MANAGEMENT LP | 3,000,000 | $1,946,400 | 0.10% |
CAPSTONE INVESTMENT ADVISORS, LLC | 23,393,000 | $15,177,378 | 0.07% |